Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143953 |
| CAS No | NA |
| Mol.F. | C8H19N5O |
| Mol.Wt. | 201.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143954 |
| CAS No | NA |
| Mol.F. | C2H3N5O |
| Mol.Wt. | 113.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143955 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143956 |
| CAS No | 139615-59-1 |
| Mol.F. | C3H6N2O |
| Mol.Wt. | 86.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143957 |
| CAS No | 36147-29-2 |
| Mol.F. | C3HN3O |
| Mol.Wt. | 95.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143958 |
| CAS No | NA |
| Mol.F. | C9H16N2O4 |
| Mol.Wt. | 216.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143959 |
| CAS No | 61467-70-7 |
| Mol.F. | C5H10N2O2 |
| Mol.Wt. | 130.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143960 |
| CAS No | 89614-31-3 |
| Mol.F. | C5H11N3O2 |
| Mol.Wt. | 145.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143961 |
| CAS No | NA |
| Mol.F. | C22H17FN6O3 |
| Mol.Wt. | 432.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143962 |
| CAS No | NA |
| Mol.F. | C11H17N5O : 2(HBr) |
| Mol.Wt. | 235.3 : 2(80.9) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143963 |
| CAS No | NA |
| Mol.F. | C11H17N5O : 2(HBr) |
| Mol.Wt. | 235.3 : 2(80.9) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143964 |
| CAS No | NA |
| Mol.F. | C2H5N3O2 |
| Mol.Wt. | 103.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143965 |
| CAS No | NA |
| Mol.F. | C9H11N3O |
| Mol.Wt. | 177.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143966 |
| CAS No | NA |
| Mol.F. | C5H7D5N2O |
| Mol.Wt. | 121.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143967 |
| CAS No | NA |
| Mol.F. | C5H10N2O3 |
| Mol.Wt. | 146.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143968 |
| CAS No | NA |
| Mol.F. | C7H14N4O |
| Mol.Wt. | 170.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |